Vitamin D Improves the Treatment of Allergic Rhinitis
A recent study conducted at the
It was a 2 weeks, placebo controlled study. All
patients received daily Fluticasone 100 mcg a day into each nostril. In
addition, patients were randomized to receive daily oral vitamin D 4,000
IU or a placebo.
At baseline the average vitamin D level was 30 ng/ml.
By the end of the 2 weeks, it rose to an average of 37 ng/ml in vitamin
D treated patients. In the placebo group, vitamin D level did not change
Vitamin D cut down symptom score by 6.9 points
compared to 3.7 points for placebo group. The effect was apparent by Day
2 and remained significant throughout the study period. The
investigators were shocked at the results.
The study was presented at the 2012 Annual meeting of
This article was written by Sarfraz Zaidi, MD, FACE. Dr. Zaidi specializes in Diabetes, Endocrinology and Metabolism.
Dr. Zaidi is a former Assistant Clinical Professor of Medicine at UCLA. Currently he is Medical Director of the Jamila Diabetes and Endocrine Medical Center in Thousand Oaks, California.
Copyright © All rights reserved.